ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,928Medicare Part D Prescriptions Filled, Including Refills

Rank: 123 out of 395

$622K Total Retail Price of All Prescriptions

Rank: 47 out of 395

273 Patients Receiving at Least One Drug in Part D
68% Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nevada
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

23% of this provider’s 273 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%. This is far more than peers.

Prescription Price

$90 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nevada
HYDROCODONE-ACETAMINOPHEN 204 108 56 S3 1 5
SIMVASTATIN 196 166 42 2 2
LEVOTHYROXINE SODIUM 183 125 35 3 3
AMLODIPINE BESYLATE 174 135 33 4 4
CRESTOR 161 105 28 5 53
LISINOPRIL 155 77 41 6 1
LOSARTAN POTASSIUM 145 123 29 7 9
TRAMADOL HCL 125 103 40 8 30
METFORMIN HCL 120 85 36 9 7
CLOPIDOGREL 115 96 27 10 21
LIDODERM 112 101 12 11 147
GABAPENTIN 111 62 32 12 12
OMEPRAZOLE 109 55 26 13 6
ATORVASTATIN CALCIUM 97 78 19 14 8
ALPRAZOLAM 89 36 15 B 15 14
TAMSULOSIN HCL 84 61 16 16 24
CLONAZEPAM 82 <11 <11 B 17 66
CIPROFLOXACIN HCL 76 58 65 18 54
MELOXICAM 75 40 18 19 51
ZOLPIDEM TARTRATE 73 40 21 20 18
RANITIDINE HCL 73 33 12 20 37
SPIRIVA 72 48 16 22 47
ATENOLOL 70 50 14 23 15
LYRICA 69 <11 <11 24 129
METFORMIN HCL ER 67 37 18 25 62
LOVAZA 64 <11 <11 26 109
METOPROLOL TARTRATE 64 52 13 26 11
CARISOPRODOL 63 <11 <11 R 28 65
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 42 17 29 27
TEMAZEPAM 61 56* 24 B 30 33
ONGLYZA 58 <11 <11 31 167
ADVAIR DISKUS 57 29 13 32 50
VENTOLIN HFA 54 23 12 33 46
METOCLOPRAMIDE HCL 52 <11 <11 34 133
FAMOTIDINE* 51 17 14 35 70
PROAIR HFA 50 31 20 36 63
NAMENDA 50 <11 <11 36 45
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.